Novartis imports some 120 million packs of medicines into the UK each year.
Keystone
Swiss pharmaceuticals giant Novartis says a no-deal Brexit could hurt patients and that it is stockpiling medicines in the UK to help ensure continuity of supply.
This content was published on
1 minute
swissinfo.ch/jc
In a press release on Friday, it said that after the British parliament’s rejection of Prime Minister Theresa May’s Brexit deal, “the risk of UK exiting the EU without a deal is increased and this will be hugely impactful for patients, particularly around the supply and safety of medicines”.
And it called for the British government to take action on medicines.
“It is vital that Government makes minimising disruption to the medicines supply the highest priority as it prepares for a potential hard or disorderly Brexit and ensures cooperation over medicines regulation in this event.”
The pharma giant said it is prioritising measures to ensure that patients in the UK can access medicines produced by Novartis and its Sandoz and Alcon affiliates. It imports some 120 million packs of medicines to the UK from Europe each year, according to the press release.
Novartis also urged the National Health Service and pharmacists in the UK to heed advice not to stockpile medicines, “so supply can be managed centrally, minimising the risk of medicine shortages across the UK”.
Novartis, maker of neurological, immunology and cancer drugs, employs around 1,500 people in the UK.
More
More
Brexit worries to keep Theresa May away from Davos
This content was published on
UK Prime Minister Theresa May, citing domestic concerns, has followed her French and American counterparts by pulling out of this year’s WEF.
Is reforming the Swiss pension system still possible, and if so, how?
Solutions still need to be found to meet the challenge of an ageing population and to improve the pensions of low-paid workers, the majority of whom are women.
Swiss to reduce administrative burden on farms from 2026
This content was published on
From 2026, the number of inspections of farms is to be reduced, without any loss of quality, said economics minister Guy Parmelin.
Swiss insurance boss proposes Singapore-style healthcare system
This content was published on
CEO of Swiss health insurer Sanitas has said that healthcare costs could be reduced if Switzerland were to follow the Singapore model.
Swiss minister talks crime and security in visit to the Netherlands
This content was published on
Swiss justice minister Beat Jans spent two days in the Netherlands discussing security, police cooperation and justice with international bodies.
Study finds more heavy metal detected in Swiss grassland
This content was published on
Copper and zinc can be expected to accumulate in the soil, particularly if farmyard manure is used for several years and is greater than the amount of nutrients absorbed by the grass. This was announced by the Federal Office for the Environment (FOEN) on Friday. The findings are based on the results of the seventh National Soil Monitoring of Switzerland (Nabo).
Lilo Baur wins Swiss Grand Prix for performing arts
This content was published on
The Swiss actress and theatre director Lilo Baur has received this year's Swiss Grand Prix for Performing Arts, also known as the Hans Reinhart Ring.
Court rules al-Qaeda supporter can stay in Switzerland
This content was published on
A Kurdish supporter of the Islamist terrorist network al-Qaeda can stay in Switzerland, the Federal Administrative Court has ruled. It has withdrawn the annulment of the man’s provisional admission.
This content was published on
The Office of the Attorney General of Switzerland (OAG) has closed criminal proceedings relating to the Swiss owners affected by the Volkswagen “Dieselgate” emissions scandal.
This content was published on
The employment outlook in Switzerland will remain stable towards the end of 2024, according to the KOF Swiss Economic Institute at ETH Zurich.
Swiss woman accuses Donald Trump of sexual assault
This content was published on
A former Miss Switzerland candidate has accused Donald Trump of sexually assaulting her in New York in 1993. The US Republican candidate’s campaign team has denied the accusations.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis weighs reinsurance tie-up to fund ultra-expensive drugs
This content was published on
Swiss drugmaker Novartis is exploring working with the global reinsurance industry to help bear the cost of new personalised therapies.
Too few pharma companies prioritise access to medicines
This content was published on
Novartis and Roche both get a boost in the 2018 ranking of progress in expanding access to medicines by the biggest pharmaceutical companies.
This content was published on
Sandoz Inc. and Pear Therapeutics announced that that an app to help treat opium addicts was approved in the United States.
The pharma holy grail: drugs for you, designed by you
This content was published on
In the age of sensors, wearables, and artificial intelligence (AI), almost everything can be customised for the individual.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.